BHVN Biohaven Pharmaceutical Holding Company Ltd
2,305
$38.72
$0.60
(1.53%)
| Watchers | 2,305 |
| 52-Wk Low | $14.96 |
| 52-Wk High | $62.21 |
| Market Cap | $3.42B |
| Volume | 74.00 |
| 52-Wk High | $62.21 |
| 52-Wk Low | $14.96 |
Biohaven Reports First Quarter 2024 Financial Results and Recent Business DevelopmentsPR Newswire • 13 days ago
Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments PR Newswire NEW HAVEN...
Share to Feed
Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares Biohaven Announces Closing of Public Offering and Full Exercise of the...
Biohaven Announces Pricing of $230 Million Public Offering of Common Shares Biohaven Announces Pricing of $230 Million Public Offering of Common Shares PR Newswire NEW HAVEN, Conn., April 18, 2024...
Biohaven Announces Proposed Public Offering of Common Shares Biohaven Announces Proposed Public Offering of Common Shares PR Newswire NEW HAVEN, Conn., April 17, 2024 NEW HAVEN, Conn., April 17, 2024...
Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business Updates Biohaven Showcases...
Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business...
Biohaven Highlights Progress Across Innovative Portfolio and Outlines 2024 Anticipated Milestones at the 42nd Annual J.P. Morgan Healthcare Conference; Established Extensive Portfolio Across 20...
Biohaven to Present at the 42nd Annual J.P. Morgan Healthcare Conference Biohaven to Present at the 42nd Annual J.P. Morgan Healthcare Conference PR Newswire NEW HAVEN, Conn., Jan. 2, 2024 NEW HAVEN...